Stacey Ness, PharmD, CSP, MSCS, AAHIVP

PCSK9 inhibitors are among the most significant tools targeting high cholesterol to arrive since the first statins were approved by the FDA.

Long-term care pharmacies have seen significant growth among select specialty categories.